A complete Guide to Human Microbiomes Across Body Sites

Microbial Metallomics and the Human Microbiome

The human microbiome is more than a list of bacterial species; it behaves as a distributed organ that co-develops with the host, shapes immunity and metabolism, and responds dynamically to environment, diet, and drugs. Microbial metallomics places metals and metalloids at the center of this organ. It asks how microbes acquire, store, and exchange elements such as iron, zinc, copper, manganese, and selenium, how these processes are regulated by the host, and how disturbed metal flows contribute to disease. In this view, the microbiome is not only a genetic or metabolic reservoir, but also a finely tuned metal-handling system embedded in human physiology.

Early-Life Microbiome Assembly and Elemental Demands

Colonization begins at birth and is shaped by delivery mode, breastfeeding, early antibiotics, and environment. Vaginal delivery and breastfeeding favor Lactobacillus, Bifidobacterium, and other taxa adapted to human milk oligosaccharides and trace element availability. In contrast, C-section, formula feeding, and early-life antimicrobial exposure promote communities enriched in Enterobacteriaceae and staphylococci with distinct iron-scavenging and metal-resistance profiles. These early metallomic strategies influence epithelial barrier maturation, redox balance, and immune education. From a clinical perspective, early-life interventions may recalibrate long-term risk for allergy, autoimmunity, and obesity partly by reshaping microbial and host metal homeostasis.

Site-Specific Microbiomes as Metal Niches

Each anatomical site establishes its own “metal niche.”
In the vagina, lactobacilli maintain acidic pH, produce lactic acid and bacteriocins, and modulate local metal availability. Loss of these taxa is associated with bacterial vaginosis, increased susceptibility to sexually transmitted infections, and adverse pregnancy outcomes, all occurring within a changed metal and redox environment.
Skin, ocular, and auditory surfaces are low-nutrient, often metal-limited habitats, selecting for organisms with robust metal transport, detoxification, and oxidative stress responses.
The gut, with its dense microbial biomass, steep oxygen gradients, and complex diet-derived ligands, is a particularly rich metallomic ecosystem where metal speciation, bile acids, and microbial metabolites interact to shape community structure and host absorption.

Metals, Microbial Dysbiosis, and Metabolic Disease

Obesity and type 2 diabetes are consistently linked to gut dysbiosis: reduced short-chain fatty acid (SCFA) producers, enrichment of endotoxin-producing Proteobacteria, and altered bile acid metabolism. Superimposing metallomics reveals additional mechanisms. SCFAs influence luminal pH and metal speciation, modulating absorption of iron, zinc, and magnesium. Chronic low-grade inflammation increases hepcidin, sequestering iron in host tissues and changing luminal iron pools, thereby selecting for microbes with high-affinity siderophores. Trace element deficiencies or excess (zinc, copper, manganese) further shift microbial composition, oxidative stress handling, and insulin signaling. Metabolic disease thus emerges as a disorder of the metal–microbe–host axis, not solely of calories or taxa.

Microbial Metallomics in Pharmacology and Cancer Immunotherapy

The microbiome is now recognized as a major modifier of drug disposition, efficacy, and toxicity. Many microbial enzymes that activate or inactivate drugs are metalloenzymes, relying on iron–sulfur clusters, heme, or zinc-dependent catalytic sites. Microbial competition for metals and alteration of host transporters can influence levels of metal-binding drugs and biologics. In oncology, specific gut microbiome configurations are associated with improved responses to immune checkpoint inhibitors. Microbial metabolites may reshape epithelial redox status and metal transporter expression, indirectly modulating antitumor immunity. Integrating metallomic profiling with microbiome analysis could refine prediction of treatment response and guide supportive interventions, for example tailored micronutrient and probiotic strategies during chemotherapy or immunotherapy.

The Gut–Brain–Metal Axis

Microbiome alterations have been implicated in autism spectrum disorder, depression, anxiety, and neurodegenerative diseases. Microbial metabolites such as SCFAs, tryptophan catabolites, and bile acid derivatives interact with the nervous and immune systems. Metals add a further regulatory layer. Gut microbes influence absorption and systemic distribution of copper, iron, and zinc—elements essential for synaptic plasticity, myelination, and neurotransmitter metabolism. Dysbiosis-driven inflammation increases permeability of the gut and blood–brain barriers, potentially altering brain exposure to metal species and promoting microglial activation. Microbial metallomics therefore offers testable hypotheses for combined microbiome- and metal-targeted approaches in neuropsychiatric and neurodegenerative conditions.

Future Directions for Metal-Aware Microbiome Medicine

Modern lifestyles—ultra-processed diets, urbanization, disinfectant use, and environmental pollutants, reshape both microbial diversity and exposure to metals and metal-mimicking chemicals. Precision microbiome interventions should deliberately incorporate metallomic thinking. Candidate strains can be selected based on defined metal uptake and export systems, siderophore repertoires, and antioxidant capacities. Dietary and supplemental metal intake can be aligned with these microbial traits to stabilize desired communities. Clinically, integrating elemental profiling, metal–metabolite complexes, and microbial composition could yield biomarkers of microbiome resilience and disease risk. In summary, framing the human microbiome as a metal-structured organ system opens a powerful conceptual path for diagnosis, prevention, and therapy across disciplines.

Citation

Reynoso-García J, Miranda-Santiago AE, Meléndez-Vázquez NM, et al. A complete guide to human microbiomes: Body niches, transmission, development, dysbiosis, and restoration. Front Syst Biol. 2022;2:951403. doi:10.3389/fsysb.2022.951403